Skip to Main Content

Paper Details

New Ameloblastoma Cell Lines Enable Preclinical Study of Targeted Therapies.
J Dent Res
7
2022
Author NameAffiliation
Jonathan R PollackStanford University School of Medicine
  • 1 - 1

Datasets

Release 1.2